Combining drug and gene similarity measures for drug-target elucidation

Journal of Computational Biology

Volumn 18, Issue 2, 2011, Pages 133-145

  Perlman, Liat ^a   Gottlieb, Assaf ^a   Atias, Nir ^a   Ruppin, Eytan ^a   Sharan, Roded ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

computational molecular biology; gene expression; gene networks; genetic variation; machine learning; sequence analysis

Indexed keywords

DRUG;

ALGORITHM; AREA UNDER THE CURVE; BIOLOGY; CONFERENCE PAPER; DRUG SCREENING; GENE; HUMAN; METHODOLOGY; MOLECULARLY TARGETED THERAPY;

ALGORITHMS; AREA UNDER CURVE; COMPUTATIONAL BIOLOGY; DRUG EVALUATION, PRECLINICAL; GENES; HUMANS; MOLECULAR TARGETED THERAPY; PHARMACEUTICAL PREPARATIONS;

EID: 79951729882     PISSN: 10665277     EISSN: None     Source Type: Journal    
DOI: 10.1089/cmb.2010.0213     Document Type: Conference Paper

References (65)

1. Accelrys, Inc. 2009. Available at: Http://accelrys.com/products/scitegic/ . Accessed November 1, 2010.
2. Ashburner, M., Ball, C.A., Blake, J.A., et al. 2000. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29. (Pubitemid 30257031)
3. Atias, N., and Sharan, R. 2010. An algorithmic framework for predicting side-effects of drugs. RECOMB 2010 (to appear).
4. Bleakley, K., and Yamanishi, Y. 2009. Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics 25, 2397-2403.
5. Breitkreutz, B.J., Stark, C., Reguly, T., et al. 2008. The BioGRID Interaction Database: 2008 update. Nucleic Acids Res. 36, D637-D640. (Pubitemid 351149798)
6. Burns, K., Opas, M., and Michalak, M. 1997. Calreticulin inhibits glucocorticoid- but not cAMP-sensitive expression of tyrosine aminotransferase gene in cultured McA-RH7777 hepatocytes. Mol. Cell Biochem. 171, 37-43. (Pubitemid 27243950)
7. Campillos, M., Kuhn, M., Gavin, A.C., et al. 2008. Drug target identification using side-effect similarity. Science 321, 263-266. (Pubitemid 351989100)
8. Chang, C.-C., and Lin, C.-J. 2001. LIBSVM: A library for support vector machines. Available at: Http://www.csie.ntu .edu.tw/cjlin/libsvm. Accessed November 1, 2010.
9. Chen, M., Ona, V.O., Li, M., et al. 2000. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6, 797-801. (Pubitemid 30469429)
10. Cheng, A.C., Coleman, R.G., Smyth, K.T., et al. 2007. Structure-based maximal affinity model predicts small-molecule druggability. Nat. Biotechnol. 25, 71-75. (Pubitemid 46087905)
11. Davis, A.P., Murphy, C.G., Saraceni-Richards, C.A., et al. 2009. Comparative Toxicogenomics Database: A knowledgebase and discovery tool for chemical-gene-disease networks. Nucleic Acids Res. 37, D786-D792.
12. Davis, J., and Goadrich, M. 2006. The relationship between Precision-Recall and ROC curves. Proc. ICML '06 233-240.
13. di Bernardo, D., Thompson, M.J., Gardner, T.S., et al. 2005. Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat. Biotechnol. 23, 377-383. (Pubitemid 41094431)
14. Ehnholm, C., Mahley, R.W., Chappell, D.A., et al. 1984. Role of apolipoprotein E in the lipolytic conversion of betavery low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc. Natl. Acad. Sci. USA 81, 5566-5570. (Pubitemid 14000524)
15. Ewing, R.M., Chu, P., Elisma, F., et al. 2007. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 3, 89.
16. Fawcett, T. 2005. An introduction to ROC analysis. Patt. Recogn. Lett. 27, 861-874.
17. Fredholm, B.B., and Persson, C.G. 1982. Xanthine derivatives as adenosine receptor antagonists. Eur. J. Pharmacol. 81, 673-676. (Pubitemid 12057134)
18. Gardner, T.S., di Bernardo, D., Lorenz, D., et al. 2003. Inferring genetic networks and identifying compound mode of action via expression profiling. Science 301, 102-105. (Pubitemid 36801571)
19. Gunther, S., Kuhn, M., Dunkel, M., et al. 2008. SuperTarget and Matador: Resources for exploring drug-target relationships. Nucleic Acids Res. 36, D919-D922. (Pubitemid 351149845)
20. Guyon, I., and Elisseeff, A. 2003. An introduction to variable and feature selection. J. Mach. Learn. Res. 3, 1157-1182.
21. Haggarty, S.J., Koeller, K.M., Wong, J.C., et al. 2003. Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. Chem. Biol. 10, 383-396. (Pubitemid 36610312)
22. Hansen, N.T., Brunak, S., and Altman, R.B. 2009. Generating genome-scale candidate gene lists for pharmacogenomics. Clin. Pharmacol. Ther. 86, 183-189.
23. Hillenmeyer, M.E., Ericson, E., Davis, R.W., et al. 2010. Systematic analysis of genome-wide fitness data in yeast reveals novel gene function and drug action. Genome Biol. 11, R30.
24. Iorio, F., Tagliaferri, R., and di Bernardo, D. 2009. Identifying network of drug mode of action by gene expression profiling. J. Comput. Biol. 16, 241-251.
25. Jaccard, P. 1908. Nouvelles recherches sur la distribution florale. Bul. Soc. Vaudoise Sci. Nat. 44, 223-270.
26. Jain, E., Bairoch, A., Duvaud, S., et al. 2009. Infrastructure for the life sciences: Design and implementation of the UniProt website. BMC Bioinformatics 10, 136.
27. Kanehisa, M., Goto, S., Furumichi, M., et al. 2010. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355-D360.
28. Keiser, M.J., Roth, B.L., Armbruster, B.N., et al. 2007. Relating protein pharmacology by ligand chemistry. Nat. Biotechnol. 25, 197-206. (Pubitemid 46227119)
29. Keiser, M.J., Setola, V., Irwin, J.J., et al. 2009. Predicting new molecular targets for known drugs. Nature 462, 175-181.
30. Kuhn, M., Campillos, M., Gonzalez, P., et al. 2008. Large-scale prediction of drug-target relationships. FEBS Lett. 582, 1283-1290.
31. Kuhn, M., Campillos, M., Letunic, I., et al. 2010. A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 6, 343.
32. Kutalik, Z., Beckmann, J.S., and Bergmann, S. 2008. A modular approach for integrative analysis of large-scale geneexpression and drug-response data. Nat. Biotechnol. 26, 531-539. (Pubitemid 351668039)
33. Lamb, J., Crawford, E.D., Peck, D., et al. 2006. The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929-1935. (Pubitemid 44497995)
34. Li, Q., and Lai, L. 2007. Prediction of potential drug targets based on simple sequence properties. BMC Bioinformatics 8, 353.
35. Liu, Y., Hu, B., Fu, C., et al. 2010. DCDB: Drug combination database. Bioinformatics 26, 587-588.
36. Mani, K.M., Lefebvre, C., Wang, K., et al. 2008. A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Mol. Syst. Biol. 4, 169.
37. Martin, Y.C., Kofron, J.L., and Traphagen, L.M. 2002. Do structurally similar molecules have similar biological activity? J. Med. Chem. 45, 4350-4358. (Pubitemid 35025581)
38. Matthews, L., Gopinath, G., Gillespie, M., et al. 2009. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 37, D619-622.
39. MDL Drug Data Report. 2006. MDL Information Systems Inc., San Leandro, CA.
40. Mitchell, J.B. 2001. The relationship between the sequence identities of alpha helical proteins in the PDB and the molecular similarities of their ligands. J. Chem. Infect. Comput. Sci. 41, 1617-1622.
41. Mouratidis, P.X., Colston, K.W., and Dalgleish, A.G. 2007. Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells. Int. J. Cancer 120, 743-752. (Pubitemid 46175392)
42. Olah, M., Mracec, M., Ostopovici, L., et al. 2005. WOMBAT: World of Molecular Bioactivity, 221-239. In Tudor, I.O., ed., Chemoinformatics in Drug Discovery. New York.
43. Ovaska, K., Laakso, M., and Hautaniemi, S. 2008. Fast Gene Ontology based clustering for microarray experiments. BioData Min. 1, 11.
44. Podjarny, E., Benchetrit, S., Katz, B., et al. 2001. Effect of methyldopa on renal function in rats with L-NAME-induced hypertension in pregnancy. Nephron 88, 354-359. (Pubitemid 32695892)
45. Rennemeier, C., Hammerschmidt, S., Niemann, S., et al. 2007. Thrombospondin-1 promotes cellular adherence of gram-positive pathogens via recognition of peptidoglycan. FASEB J. 21, 3118-3132. (Pubitemid 47565532)
46. Resnik, P. 1999. Semantic similarity in a taxonomy: An information-based measure and its application to problems of ambiguity in natural language. J. Artif. Intell. Res. 11, 95-130. (Pubitemid 129628761)
47. Rollo, I.M. 1970. Dihydrofolate reductase inhibitors as antimicrobial agents and their potentiation by sulfonamides. CRC Crit. Rev. Clin. Lab. Sci. 1, 565-583.
48. Rual, J.F., Venkatesan, K., Hao, T., et al. 2005. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178. (Pubitemid 41509356)
49. Schuffenhauer, A., Floersheim, P., Acklin, P., et al. 2003. Similarity metrics for ligands reflecting the similarity of the target proteins. J. Chem. Inf. Comput. Sci. 43, 391-405.
50. Sinan, S., Kockar, F., and Arslan, O. 2006. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics. Biochimie 88, 565-574. (Pubitemid 43870393)
51. Skrbo, A., Begovic, B., and Skrbo, S. 2004. [Classification of drugs using the ATC system (Anatomic, Therapeutic, Chemical Classification) and the latest changes]. Med. Arh. 58, 138-141.
52. Smith, T.F., Waterman, M.S., and Burks, C. 1985. The statistical distribution of nucleic acid similarities. Nucleic Acids Res. 13, 645-656.
53. Steinbeck, C., Hoppe, C., Kuhn, S., et al. 2006. Recent developments of the chemistry development kit (CDK)-an open-source java library for chemo- and bioinformatics. Curr. Pharm. Des. 12, 2111-2120. (Pubitemid 43891407)
54. Stelzl, U., Worm, U., Lalowski, M., et al. 2005. A human protein-protein interaction network: A resource for annotating the proteome. Cell 122, 957-968. (Pubitemid 41345212)
55. Stone, K.J., and Strominger, J.L. 1971. Mechanism of action of bacitracin: Complexation with metal ion and C55- isoprenyl pyrophosphate. Proc. Natl. Acad. Sci. USA 68, 3223-3227.
56. Subramanian, A., Tamayo, P., Mootha, V.K., et al. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550. (Pubitemid 41528093)
57. Tanimoto, T.T. 1957. IBM internal report. 17 November.
58. Thomson, A.E., Squires, E.J., and Gentry, P.A. 2002. Assessment of factor V, VII and X activities, the key coagulant proteins of the tissue factor pathway in poultry plasma. Br. Poult. Sci. 43, 313-321. (Pubitemid 135746185)
59. Thor and Merlin, version 4.62. Daylight Chemical Information Systems Inc., Irvine, CA. Available at: www.daylight.com. Accessed November 1, 2010.
60. Wishart, D.S., Knox, C., Guo, A.C., et al. 2008. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36, D901-D906. (Pubitemid 351149842)
61. Xenarios, I., Salwinski, L., Duan, X.J., et al. 2002. DIP, the Database of Interacting Proteins: A research tool for studying cellular networks of protein interactions. Nucleic Acids Res. 30, 303-305. (Pubitemid 34679570)
62. Yamanishi, Y., Araki, M., Gutteridge, A., et al. 2008. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24, i232-i240. (Pubitemid 351911678)
63. Zhu, F., Han, B., Kumar, P., et al. 2010. Update of TTD: Therapeutic Target Database. Nucleic Acids Res. 38, D787-D791.
64. Zhu, S., Okuno, Y., Tsujimoto, G., et al. 2005. A probabilistic model for mining implicit "chemical compound-gene" relations from literature. Bioinformatics 21, Suppl 2, ii245-ii251. (Pubitemid 41535457)
65. Zhu, S., Stavrovskaya, I.G., Drozda, M., et al. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 74-78. (Pubitemid 34498818)